Literature DB >> 32506251

Minimally Invasive Therapies for Osteoarthritic Hip Pain: a Comprehensive Review.

Ivan Urits1, Vwaire Orhurhu2, Jordan Powell3, Anu Murthy4, Brendon Kiely4, Samara Shipon5, Rachel J Kaye6,7, Alan D Kaye6, Brett L Arron6, Elyse M Cornett6, Omar Viswanath5,6,8,9.   

Abstract

PURPOSE OF REVIEW: Osteoarthritis (OA) is a highly prevalent cause of chronic hip pain, affecting 27% of adults aged over 45 years and 42% of adults aged over 75 years. Though OA has traditionally been described as a disorder of "wear-and-tear," recent studies have expanded on this understanding to include a possible inflammatory etiology as well, damage to articular cartilage produces debris in the joint that is phagocytosed by synovial cells which leads to inflammation. RECENT
FINDINGS: Patients with OA of the hip frequently have decreased quality of life due to pain and limited mobility though additional comorbidities of diabetes, cardiovascular disease, poor sleep quality, and obesity have been correlated. Initial treatment with conservative medical management can provide effective symptomatic relief. Physical therapy and exercise are important components of a multimodal approach to osteoarthritic hip pain. Patients with persistent pain may benefit from minimally invasive therapeutic approaches prior to consideration of undergoing total hip arthroplasty. The objective of this review is to provide an update of current minimally invasive therapies for the treatment of pain stemming from hip osteoarthritis; these include intra-articular injection of medication, regenerative therapies, and radiofrequency ablation.

Entities:  

Keywords:  Corticosteroids; Hip osteoarthritis; Hyaluronic acid; Intra-articular injection; Platelet-rich plasma; Radiofrequency ablation; Viscosupplementation

Mesh:

Substances:

Year:  2020        PMID: 32506251     DOI: 10.1007/s11916-020-00874-8

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  4 in total

Review 1.  The role for high volume local infiltration analgesia with liposomal bupivacaine in total hip arthroplasty: A scoping review.

Authors:  Neeraj Vij; Rajesh Supra; Delena Vanvalkenburg; Nicholas Comardelle; Alan D Kaye; Omar Viswanath; Ivan Urits
Journal:  Orthop Rev (Pavia)       Date:  2022-08-05

2.  Prior Intra-articular Corticosteroid Injection Within 3 Months May Increase the Risk of Deep Infection in Subsequent Joint Arthroplasty: A Meta-analysis.

Authors:  Qizhong Lai; Kaishen Cai; Tianye Lin; Chi Zhou; Zhenqiu Chen; Qingwen Zhang
Journal:  Clin Orthop Relat Res       Date:  2021-12-17       Impact factor: 4.755

3.  Safety of Intra-articular Hip Corticosteroid Injections: A Matched-Pair Cohort Study.

Authors:  Paul F Abraham; Nathan H Varady; Kirstin M Small; Nehal Shah; Luis S Beltran; Michael P Kucharik; Scott D Martin
Journal:  Orthop J Sports Med       Date:  2021-10-25

Review 4.  A review of the efficacy of intraarticular hip injection for patients with hip osteoarthritis: To inject or not to inject in hip osteoarthritis?

Authors:  Sanjiv Rampal; Ashish Jaiman; Mehmet Ali Tokgöz; Gayathri Arumugam; Sureshan Sivananthan; Rashdeep Singh Jagdeb Singh; Syafiqah Binti Zazali; Maziar Mohaddes
Journal:  Jt Dis Relat Surg       Date:  2022-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.